H3 Biomedicine publishes comprehensive analysis of RNA splicing factor genes in multiple types of cancer

April 4, 2018 Leave a comment 2,317 Views

Novel findings underscore promise of H3 Biomedicine’s first-in-class splicing factor modulator H3B-8800 currently in Phase 1 clinical trial for patients with hematologic cancers and splicing factor...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: H3 Biomedicine

H3 Biomedicine publishes comprehensive analysis of RNA splicing factor genes in multiple types of cancer

Circall – fast and accurate methodology for discovery of circular RNAs from paired-end RNA-sequencing data

Single-cell analysis support the use of PDAC organoids as a clinically relevant model for in vitro studies of tumor heterogeneity

lncRNA Regulation of IFNɣ and Its Effect on Checkpoint Inhibitor Expression Enhances Understanding of Therapeutic Cancer Target

Detection of atherosclerosis by small RNA-sequencing analysis of extracellular vesicle enriched serum samples

Mayo Clinic collaborates with Personalis to to offer clinical-grade comprehensive cancer genomic sequencing

Isoform variability is an important source of latent information in RNA-seq data that can be used to improve clinical prediction models.

Transcriptome-wide RNA-protein interaction predictions